Polycomb Group Genes: Keeping Stem Cell Activity in Balance
Open Access
- 29 April 2008
- journal article
- editorial
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 6 (4) , e113
Abstract
Overexpression of Polycomb group genes is often associated with cancer development, whereas complete deletion results in loss of stem cell activity. New studies show that partial loss of function of Polycomb group genes enhances the activity of blood stem/progenitor cells.Keywords
This publication has 31 references indexed in Scilit:
- Polycomb Repressive Complex 2 (PRC2) Restricts Hematopoietic Stem Cell ActivityPLOS Biology, 2008
- Suz12 is essential for mouse development and for EZH2 histone methyltransferase activityThe EMBO Journal, 2004
- Role of histone H2A ubiquitination in Polycomb silencingNature, 2004
- Stem Cells and CancerCell, 2004
- EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cellsProceedings of the National Academy of Sciences, 2003
- Bmi-1 determines the proliferative capacity of normal and leukaemic stem cellsNature, 2003
- Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste proteinGenes & Development, 2002
- The polycomb group protein EZH2 is involved in progression of prostate cancerNature, 2002
- Crystal structure of the nucleosome core particle at 2.8 Å resolutionNature, 1997
- bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis.1993